Friday, September 22, 2017
 
 
Company News: Page (1) of 1 - 09/13/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Corporate Whistleblower Center Now Urges a Drug Company Insider to Call Them About Potentially Huge Rewards If They Have Proof Their Employer Is Overbilling Medicare or Medicaid
 
(September 13, 2017)

WASHINGTON, Sept. 13, 2017 /PRNewswire/ -- The Corporate Whistleblower Center says, "We are urging a pharmaceutical company manager or sales representative to call us anytime at 800-714-0303 if they have proof their employer is overbilling Medicare or Medicaid. The rewards for this type of information can be huge as we would like to discuss anytime.

"If you are a pharmaceutical or medical device company and you can prove your competition is cheating Medicare or Medicaid out of millions-please call us about rewards and potentially a huge competitive edge over your competition. Whistleblowers exactly like this will receive approximately $38.7 million as their share of a recent federal False Claim Act settlement. Why sit on a winning lotto ticket without ever know what it might be worth?" http://CorporateWhistleblower.Com

In August 2017, the Department of Justice announced a major settlement involving a US based pharmaceutical company had agreed to pay $465 million to resolve claims that they violated the False Claims Act by knowingly misclassifying its pharmaceutical product as a generic drug to avoid paying rebates owed primarily to Medicaid.


The settlement resolves the government's allegations that the drug company was erroneously reporting their product as a generic drug to Medicaid despite the absence of any therapeutically equivalent drugs, and the company received massive price increases in the private market while avoiding its corresponding rebate obligations to Medicaid. Between 2010 and 2016, the pharmaceutical company increased the price of their product by approximately 400 percent yet paid only a fixed 13 percent rebate to Medicaid during the same period. The government further alleged that although the drug company was well-aware that its drug was not a generic, it nevertheless claimed generic status for its product in the Medicaid program to avoid paying a higher rebate.

Simple rules for a whistleblower from the Corporate Whistleblower Center: Do not go to the government first if you are a major whistleblower. The Corporate Whistleblower Center says, "Major whistleblowers frequently go to the government thinking they will help. It's a huge mistake. Do not go to the news media with your whistleblower information. Public revelation of a whistleblower's information could destroy any prospect for a reward. Do not try to force a company or individual to come clean on Medicare overbilling or Come to us first, tell us what type of information you have, and if we think it's sufficient, we will help find the right law firms to assist in advancing your information. Our number one goal is to make certain a whistleblower who can prove multi-million-dollar Medicare or Medicaid fraud receives the best possible financial compensation as we would like to explain anytime at 866-714-6466." http://CorporateWhistleblower.Com

The Corporate Whistleblower Center is specifically focused on from potential whistleblowers from the following types of healthcare companies-if they over billing Medicare or Medicaid:

  • Hospitals
  • Skilled Nursing Facilities
  • Nursing Homes
  • Dialysis Centers
  • Hospice Centers
  • Imaging Centers
  • Rehab Centers
  • Blood Testing Labs

The Corporate Whistleblower Center wants to emphasize there are high quality whistleblowers in every state, including California, New York, New Jersey, Florida, Texas, Massachusetts, Maryland, Rhode Island, Virginia, Ohio, Pennsylvania, West Virginia, Tennessee, North Carolina, Georgia, Alabama, Mississippi, Louisiana, Missouri, Illinois, Indiana, Wisconsin, Minnesota, North Dakota, Nebraska, Colorado, Arizona, Nevada, Washington, or Alaska. They are especially interested in hearing from medical doctors who have information about significant Medicare overbilling-or fraud in their state. 

The Corporate Whistleblower Center is the premier advocate for whistleblowers in the United States. Unlike any group in the US, they can assist a potential whistleblower with packaging their information and providing the whistleblower with access to the most accomplished whistleblower attorneys in the nation. For more information, potential whistleblowers can contact the Corporate Whistleblower Center at 866-714-6466 or visit http://CorporateWhistleblower.Com.

For attribution to this recent whistleblower reward please refer to the August 2017 Department of Justice press release on this matter. https://www.justice.gov/opa/pr/mylan-agrees-pay-465-million-resolve-false-claims-act-liability-underpaying-epipen-rebates.

Media Contact:
Thomas Martin
[email protected] 
866-714-6466

View original content with multimedia:http://www.prnewswire.com/news-releases/corporate-whistleblower-center-now-urges-a-drug-company-insider-to-call-them-about-potentially-huge-rewards-if-they-have-proof-their-employer-is-overbilling-medicare-or-medicaid-300518658.html

SOURCE Corporate Whistleblower Center

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Medicine, Insurance, healthcare, Surgery, Medication, Seniors Health, Seniors, Insurance Companies, Science, Medical, Judicial,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines